Alterome Therapeutics
San Diego, United States· Est. 2021
Alterome is a clinical-stage precision oncology company developing first-in-class, alteration-specific therapies for AKT E17K- and KRAS-driven cancers.
Private Company
Total funding raised: $207M
About
Alterome is a clinical-stage precision oncology company developing first-in-class, alteration-specific therapies for AKT E17K- and KRAS-driven cancers.
Oncology
Funding History
2Total raised:$207M
Series B$75MOct 15, 2023
Series A$132MJan 15, 2022